Tart Cherry for Anti-Inflammatory

Research suggests that tart cherry, particularly in juice concentrate or powdered form, has meaningful anti-inflammatory and antioxidant properties supported by a broad range of study types, including meta-analyses, randomized controlled trials, reviews, animal studies, and cell-based research. Studies indicate that tart cherry's bioactive polyphenols and anthocyanins appear to reduce markers of inflammation and oxidative stress across multiple contexts, including exercise recovery in athletes, gout management, obesity-related cardiac stress in animal models, and chronic disease-associated inflammation, with proposed mechanisms involving key inflammatory signaling pathways such as NF-κB and MAPK. The overall direction of the evidence is supportive, though several important limitations temper strong conclusions: a 2021 review found significant inconsistencies in how studies characterize and report polyphenol content, making it difficult to compare results or establish reliable dosing relationships, and a 2024 crossover trial found no advantage of tart cherry juice over a standard sports drink for exercise recovery outcomes in recreational cyclists. The evidence base is promising but still maturing, with researchers noting that many findings from animal and cell models have yet to be fully confirmed in well-controlled human trials, and that study design variability continues to complicate direct comparisons across the literature.